SubjectsSubjects(version: 945)
Course, academic year 2023/2024
   Login via CAS
Biomedicine and biotechnology - B02981 (elective subject)
Title: Biomedicína a biotechnologie
Guaranteed by: BIOCEV, First Faculty of Medicine, Charles University (11-00131)
Faculty: First Faculty of Medicine
Actual: from 2021
Semester: summer
Points: 2
E-Credits: 2
Examination process: summer s.:
Hours per week, examination: summer s.:14/0, C [HS]
Extent per academic year: 14 [hours]
Capacity: 20
Min. number of students: 5
4EU+: no
Virtual mobility / capacity: no
State of the course: taught
Language: English, Czech
Teaching methods: full-time
Teaching methods: full-time
Explanation: tstopka@lf1.cuni.cz
Additional information: https://biocev.lf1.cuni.cz/
Note: course for students of another faculty
course can be enrolled in outside the study plan
enabled for web enrollment
Guarantor: prof. MUDr. Tomáš Stopka, Ph.D.
Attributes: Lékařství
Teoretický předmět
Annotation -
Last update: Marcela Holanová (01.02.2023)
This subject focuses on educating students in biomedical research and biotechnologies. It teaches the basis of scientific work, introduction to methodology in biomedicine up to the development of novel diagnostics and therapeutics. Lectures and seminars will contain the insight into modern tools such as transgenic biology or global technologies such as OMICs.
Teaching methods - Czech
Last update: Ing. Lucie Vyšatová (31.01.2024)

Lectures will be held in BIOCEV (Seminary Room U2.020 - Průmyslová 595, 252 50 Vestec) starting February 22nd 2024 from 4 pm. In case of questions, please do not hesitate to contact Lucie Vyšatová (lucie.vysatova@lf1.cuni.cz).

Education plan -
Schedule by date
Day Date Description Teacher Files Note Hodnocení
Thursday22.02.2024Title: Protein engineering in biomedicine State-of-the-art protein engineering is progressively asserting itself in biomedicine in a plethora of tasks such as adjustment, amplification, or attenuation of immune responses, development of new diagnostic and therapeutic modalities, and strategies to treat multiple infectious, autoimmune, and neoplastic diseases. RNDr. Jiří Zahradník, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday07.03.2024Title: Tumor ecosystem Tumors are composed of cancer cells as well as non-malignant cells such as infiltrating leukocytes and cancer-associated fibroblasts. These non-malignant cells participate in the control of cancer cell differentiation, proliferation and migration via extensive intercellular dialogue utilizing the paracrine secretion of many bioactive factors. The principle of their activity will be shown as an example of cancer-associated fibroblasts. prof. MUDr. Karel Smetana, DrSc.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday21.03.2024Title: CLINICAL PROTEOMICS Using efficient separation methods and high-resolution mass spectrometry PROTEOMICS enables monitoring of quantitative and qualitative changes of thousands of proteins in biological samples. Detailed knowledge of proteome changes in cells and tissues can elucidate molecular mechanisms of physiologic and pathologic processes, and identify disease markers or novel therapeutic targets. doc. RNDr. Jiří Petrák, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday04.04.2024Title: CELL BIOLOGY : Stem cell biology versus proliferation and differentiation control Regulatory mechanisms in normal cell differentiation including transcription factors and their effector pathways. Biology of stem cells and tissue transplantation. Regulation of cell cycle and its detection. prof. MUDr. Tomáš Stopka, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday18.04.2024Title: Biology of solid tumors and translational medicine Basic principles of cancer development, cancer driver mutations and targeted therapy, cancer evolution and progression, cancer cell dormancy and invasiveness, circulating tumor cells. RNDr. Radoslav Janoštiak, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday02.05.2024Title: GENETICS : Cancer genomes and genome editing technology Cancer associated acquired DNA mutations and their role in tumor development, progression, and therapy resistance. Consequences for interaction of tumor cells with immune system. Use of genome modifying technologies to create models for cancer research and options for therapy. doc. MUDr. Ondřej Havránek, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday16.05.2024Title: Leukocyte migration and immunology Migration of leukocytes in healthy and pathological states. Imaging of leukocyte behaviour and interactions. Cell biology of leukocyte motility. Mgr. Miroslav Hons, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
Thursday30.05.2024Title: Redox Biology Reactive oxygen and nitrogen species are not just harmful by-products that cause damage to macromolecules and ultimately cell death. They are essential signaling molecules that play a role in basic biological processes, so-called "redox signaling". The basic principles of redox signalling, its role in physiological cellular processes and in cancer will be discussed. RNDr. Kristýna Pimková, Ph.D.Students are encouraged to read education material ahead of the seminar available at: https://biocev.lf1.cuni.cz/vyuka
 
Charles University | Information system of Charles University | http://www.cuni.cz/UKEN-329.html